All 16 and 17-year-olds in the UK will be offered a first dose of the COVID-19 vaccine without parental agreement in the coming weeks, according to the Joint Committee on Vaccine and Immunization (JCVI).

The first Pfizer-BioNTech vaccine will be given to them, and guidance on when to provide the second dosage will be given later, the JCVI reported on Wednesday, August 4.

Pfizer-BioNTech is the only vaccine presently licensed for children under the age of 18 in the United Kingdom.

The JCVI held off on expanding vaccinations to 16 and 17-year-olds last month because it needed more time to assess the danger and advantages, as well as concerns of rare side effects such as heart inflammation, according to the BBC.

However, these reactions were “extremely rare” and usually happened within a few days following a second dose, with young males being more affected, the committee said on Wednesday, August 4.

Around 1.4 million teens will be accessible to the jabs as a result of this recommendations’ adjustment.

There was plenty of the vaccine on hand, said Prof Jonathan Van-Tam, England’s deputy chief medical officer. “We have the supply and I’m expecting this to start in a very short number of weeks indeed.” he continued, adding that children would soon return to sixth forms and colleges.

Prime Minister Boris Johnson advised people to “listen to the JCVI” and get the vaccine after the report. “They are extremely expert, they’re amongst the best, if not the best in the world–they know what’s safe and I think we should listen to them and take our lead from them,” he stated.

However, COVID poses an extremely minimal risk of serious illness in almost all children and adolescents. In less than a week, most coronavirus-infected youngsters recover, new research reported.

The cases of heart inflammation suffered by children under 17 years of age have now reached 397; after the application of Pfizer vaccines against the CCP virus, which was stated in the weekly report of the CDC, as of July 30, based on data voluntarily provided by users of the system.

In addition to heart inflammation, 9,246 adverse side effects, including 14 deaths, were reported between Dec. 14 and July 16.

The profusion of vaccines produced in the short period of a few months after the appearance of the CCP virus is one of the elements that generates doubts among people who have not yet decided to take this medicine.

In a world record period, 19 vaccines were delivered to consumers. FDA granted emergency approval to vaccines developed by Pfizer, Moderna, and Johnson & Johnson in less than a year, even though the process usually takes 10 to 15 years.

While big pharmaceuticals increase their revenues disproportionately by producing billions of doses, governments support vaccination campaigns by imposing restrictions on those who do not take the medicine.

However, even those who take them are not free from limitations to their freedom since they do not see any health relief because they continue to infect and contaminate others and, in many cases, must wear masks.

In addition, they are more likely to be pressured to continue taking additional doses, as was recently announced about a third ‘booster’ dose for people over 60 years of age in Israel.